World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
48
Citations
31916
World Ranking
2651
National Ranking
64

Marina Pajic publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Marina Pajic sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 124 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Marina Pajic D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Marina Pajic sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 48 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Marina Pajic is affiliated with the Garvan Institute of Medical Research in Australia. Their research primarily focuses on the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with significant contributions to Oncology, Molecular Biology, Cancer Research, Epidemiology, and Pulmonary and Respiratory Medicine.

The scientist's work covers several main topics, including:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Neuroendocrine Tumor Research Advances
  • Cancer Cells and Metastasis
  • CRISPR and Genetic Engineering
  • Cancer Immunotherapy and Biomarkers

Marina Pajic has contributed to publications in several notable venues. Frequent publication venues include:

  • Cancer Research
  • Gastroenterology
  • Science Advances
  • Research Square
  • Cell Reports

Among recent papers associated with Marina Pajic are:

  • Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer, 2020, Gastroenterology
  • HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer, 2020, Cell Reports
  • Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, 2021, Cancer Research
  • MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer, 2020, Science
  • DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association, 2021, Communications Biology

Marina Pajic has collaborated frequently with several coauthors, with multiple papers coauthored alongside:

  • Sean Porazinski (16 collaborations)
  • Paul Timpson (15 collaborations)
  • David K. Chang (11 collaborations)
  • Andrew V. Biankin (10 collaborations)
  • Amber L. Johns (9 collaborations)

Best Publications

  • Signatures of mutational processes in human cancer

    Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

  • Genomic analyses identify molecular subtypes of pancreatic cancer

    Bailey P;Chang Dk;Nones K;Nones K;Johns Al

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Whole genomes redefine the mutational landscape of pancreatic cancer.

    Nicola Waddell;Marina Pajic;Ann Marie Patch;David K. Chang

  • Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

    Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras

  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

    Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Whole-genome landscape of pancreatic neuroendocrine tumours

    Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo

  • Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer

    Sven Rottenberg;Anders O. H. Nygren;Marina Pajic;Fijs W. B. van Leeuwen

  • The prognostic and predictive value of serum CA19.9 in pancreatic cancer

    Jeremy L Humphris;David K Chang;David K Chang;Amber L Johns;Christopher J Scarlett;Christopher J Scarlett

  • Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

    Claire Vennin;Claire Vennin;Venessa T. Chin;Venessa T. Chin;Sean C. Warren;Sean C. Warren;Morghan C. Lucas;Morghan C. Lucas

  • Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial

    Lorraine A. Chantrill;Lorraine A. Chantrill;Adnan M. Nagrial;Adnan M. Nagrial;Clare Watson;Amber L. Johns

  • Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling

    Katia Nones;Nic Waddell;Sarah Song;Ann Marie Patch

  • GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

    Paola Martinelli;Enrique Carrillo-de Santa Pau;Trevor Cox;Bruno Sainz

  • CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

    Claire Vennin;Claire Vennin;Claire Vennin;Pauline Mélénec;Pauline Mélénec;Romain Rouet;Romain Rouet;Max Nobis;Max Nobis

  • Hypermutation In Pancreatic Cancer

    Jeremy L Humphris;Ann Marie Patch;Ann Marie Patch;Katia Nones;Katia Nones;Peter J Bailey;Peter J Bailey

  • Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer

    Claire Vennin;Kendelle J. Murphy;Kendelle J. Murphy;Jennifer P. Morton;Thomas R. Cox;Thomas R. Cox

  • Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater

    David K. Chang;Nigel B. Jamieson;Nigel B. Jamieson;Amber L. Johns;Christopher J. Scarlett;Christopher J. Scarlett

  • Clinical and molecular characterization of HER2 amplified-pancreatic cancer.

    Angela Chou;Angela Chou;Angela Chou;Nicola Waddell;Mark J. Cowley;Mark J. Cowley;Anthony J. Gill;Anthony J. Gill;Anthony J. Gill

  • Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

    Stephan B. Dreyer;Rosie Upstill-Goddard;Viola Paulus-Hock;Clara Paris

Frequent Co-Authors

Andrew V. Biankin
Andrew V. Biankin University of Glasgow
Anthony J. Gill
Anthony J. Gill University of Sydney
Paul Timpson
Paul Timpson Garvan Institute of Medical Research
Sean M. Grimmond
Sean M. Grimmond University of Melbourne
James G. Kench
James G. Kench Royal Prince Alfred Hospital
Nicola Waddell
Nicola Waddell QIMR Berghofer Medical Research Institute
Mark J. Cowley
Mark J. Cowley Garvan Institute of Medical Research
Elizabeth A. Musgrove
Elizabeth A. Musgrove University of Glasgow
Christopher J. Scarlett
Christopher J. Scarlett University of Newcastle Australia
John V. Pearson
John V. Pearson QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens doors to numerous career opportunities, but it can also intersect with several other academic fields. Many students explore online options to diversify their skills or find complementary subjects. For those with a creative interest, graphic design schools online offer a chance to learn visual communication—a valuable skill in scientific publishing and data visualization.

Combining science with broader fields is possible, especially through online interdisciplinary studies bachelor programs low cost. These flexible programs let you integrate molecular biology with areas such as technology or communication.

Looking at careers beyond the lab, consider continuing your education affordably. If your passion includes history or education, investigate the cheapest online masters in history programs or explore what schools offer library science degrees. These paths can lead to roles in science writing, archives, or public outreach.

Each pathway allows you to build a unique skill set that enhances your career prospects in diverse areas related to molecular biology.

Best Scientists Citing Marina Pajic

Trending Scientists

Recently Published Articles